Improving Women's Fertility Awareness and Reducing Anxiety Through Ovarian Reserve Screening and AI Counseling
NCT07894302
Summary
This study evaluates the impact of preventive ovarian reserve screening and artificial intelligence (AI)-enabled counseling on fertility awareness and reproductive anxiety among women in Hong Kong. Hong Kong faces low birth rates, and reproductive anxiety regarding the biological clock remains a key barrier to family planning. Participants aged 25 to 38 years will be allocated to receive either anti-Müllerian hormone (AMH) blood testing combined with counseling or standard health education materials. The study compares an interactive AI conversational agent ("Shelby") with traditional written reports to evaluate whether AI communication improves comprehension of medical results, reduces anxiety, and enhances fertility intentions. Findings aim to inform future public health screening policies.
Eligibility
Inclusion Criteria: * Biologically female (assigned female at birth, with intact ovaries) * Aged 25 to 38 years * Fluent in written and spoken Chinese (Traditional or Simplified) or English * Has access to an internet-enabled smartphone or computer * Able to give electronic or written informed consent Exclusion Criteria: * Currently pregnant or breastfeeding * Known active, severe psychiatric or cognitive disorder that prevents informed - consent or completing the questionnaire * History of gynecological cancer * Currently receiving gonadotoxic chemotherapy or pelvic radiotherapy
Conditions4
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07894302